LGI4 blocking peptide product blogThe LGI4 lgi4 (Catalog #MBS151941) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s LGI4 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).
LGI4 peptide is used for blocking the activity of LGI4 antibody. Researchers should empirically determine the suitability of the LGI4 lgi4 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The LGI4 lgi4 product has the following accession number(s) (GI #21359654) (NCBI Accession #AAM49552) (Uniprot Accession #Q8N135). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 17 amino acids near the carboxy terminus of human LGI4. Brain Diseases, Nervous System Diseases, Seizures are some of the diseases may be linked to LGI4 Peptide. Brain, Ear, Ganglia, Intestine, Nerve tissues are correlated with this protein. LGI4 also interacts with the following gene(s): ADAM11, ADAM22, ADAM23.